What question did this study set out to answer?

The aim is to characterize candidate variants underlying autosomal recessive non-syndromic hearing loss in Iranian families.

June 5, 2026Open Access

Molecular diagnosis of non-syndromic hearing loss in seven Iranian families using whole-exome sequencing

FAFateme Zahedi AbghariIran University of Medical Sciences EEEmran EsmaeilzadehGeneration Foundation SBSajjad BiglariIsfahan University of Medical Sciences

Key Points

The aim is to characterize candidate variants underlying autosomal recessive non-syndromic hearing loss in Iranian families.
Conducted GJB2 screening and whole-exome sequencing in seven probands with sensorineural hearing loss.
Performed copy-number variation analysis and bioinformatic filtering of variants.
Conducted in silico analysis and segregation studies to assess candidate variants' relevance.
Nine candidate variants identified across five genes, including six missense, two splice site, and one nonsense variant.
Novel variants found in LOXHD1 and TMC1 genes from unrelated families.
Identification of rare variants contributes to understanding the genetic basis of ARNSHL.

Abstract

BACKGROUND: Congenital hearing loss is a common and genetically diverse sensory disorder. Non-syndromic forms are often inherited in an autosomal recessive pattern, with the types and frequencies of clinically relevant variants differing across populations. Studies of consanguineous families have been instrumental in identifying genes associated with autosomal recessive non-syndromic hearing loss (ARNSHL). The present study aimed to characterize candidate variants potentially underlying ARNSHL in seven unrelated Iranian families with consanguinity or from the same geographic region, as reported during genetic counseling. METHODS: We conducted GJB2 screening, whole-exome sequencing (WES), and copy-number variation (CNV) analysis in seven probands with sensorineural hearing loss in the absence of additional phenotypes. Bioinformatic filtering, in silico analysis, and segregation studies were applied to determine the potential clinical relevance of candidate variants. RESULTS: WES identified nine different candidate variants in five genes among the probands and their affected family members, including six missense variants, two affecting canonical splice sites, and one nonsense variant. Previously reported variants included TMC1 (NM₁38691. 3: c. 100 C > T), SLC26A4 (NM₀00441. 2: c. 1229 C > T, c. 716T > A, c. 2027T > A), MYO7A (NM₀00260. 4: c. 247 C > T), LOXHD1 (NM₀01384474. 1: c. 4940 C > A), and CABP2 (NM₀16366. 3: c. 637 + 1G > T). Additionally, two novel variants were detected in two unrelated families: LOXHD1 (NM₀01384474. 1: c. 1136T > A) and TMC1 (NM₁38691. 3: c. 1567-1G > A). CONCLUSION: This study contributes to the current understanding of the genetic spectrum of ARNSHL in a small cohort of Iranian families by identifying rare variants in known hearing loss genes, including a novel missense variant in LOXHD1 and a novel splice-site variant in TMC1. However, due to lack of functional validation, their clinical significance remains uncertain. Further functional and large-cohort studies are needed to confirm pathogenicity and clarify genotype-phenotype relationships.

KI fragen

Bookmark

View Full Paper